- MetLife (NYSE: MET) has agreed to sell 100% of MetLife UK Limited, its closed-book UK life insurer, to Chesnara.
- The deal covers MLUK's entire share capital while excluding MetLife's ongoing UK protection business from the transaction perimeter.
- Completion is targeted for the first half of 2027, subject to regulatory approvals and customary closing conditions.
- MetLife's agreement to transfer MLUK to Chesnara is an important move to weigh alongside the rest of our findings on the group. We have also flagged 1 warning sign for MetLife.
For a wider view on how large insurers are reshaping portfolios and cash flows, it is worth comparing this move with 6 dividend fortresses.
MetLife is a global financial services group that sells insurance, annuities, employee benefits, and asset management products, so a closed-book life portfolio like MLUK sits alongside a broader mix of fee and underwriting income. This UK transfer to Chesnara relates to a mature block of policies rather than the protection business MetLife continues to offer in the market.
4 things going right for MetLife that this headline doesn't cover.
MetLife trims legacy UK risk while leaning into its New Frontier playbook
For MetLife, moving MLUK to Chesnara looks less like a dramatic pivot and more like tidying up an older block of business so the Narrative can keep centering on New Frontier execution, technology spend and international expansion. The transfer fits the existing tilt toward capital light operations and retirement platforms, rather than contradicting it. With third quarter 2026 revenue of US$20,522 million and net income of US$2,397 million, investors now have fresh numbers as context when weighing how portfolio reshaping and cost work interact with the broader earnings and buyback story.
See how these catalysts shape MetLife's path to a $107 fair value.
The cleanest early test of whether this portfolio shift helps the story is how management talks about capital deployment and returns from the ongoing UK protection and global retirement businesses at results updates through 2027, including whether quarterly free cash flow and New Frontier expense targets stay aligned with the recent earnings profile.
Add MetLife to your Watchlist and get alerts as these catalysts play out.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com